OverviewChartNewsTraderScreen

UC TUR.WAR.OP.END. N0XA/  DE000HC9PZU2  /

gettex
6/14/2024  3:46:21 PM Chg.-0.1800 Bid5:09:22 PM Ask5:09:22 PM Underlying Strike price Expiration date Option type
1.1300EUR -13.74% 1.1100
Bid Size: 35,000		 1.1200
Ask Size: 35,000		 NEXI 4.6464 EUR 12/31/2078 Call
GlobeNewswire 6/12 Worthington Enterprises Schedules Fourth Quarter 2024 Earnings Call for June 26
GlobeNewswire 6/3 Worthington Enterprises Completes Acquisition of Hexagon Ragasco
GlobeNewswire 10/24/2023 NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
GlobeNewswire 10/19/2023 NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
GlobeNewswire 10/18/2023 NexImmune Announces 1-for-25 Reverse Stock Split
GlobeNewswire 9/29/2023 Calian Launches Digital Health Portfolio of Products and Services
GlobeNewswire 9/28/2023 Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Fin...
GlobeNewswire 8/31/2023 NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development ...
GlobeNewswire 3/17/2022 NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Valida...
GlobeNewswire 3/14/2022 NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center
GlobeNewswire 3/10/2022 NexImmune to Present at the Barclays 2022 Global Healthcare Conference
GlobeNewswire 3/9/2022 NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
GlobeNewswire 2/17/2022 NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
GlobeNewswire 1/5/2022 NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GlobeNewswire 12/12/2021 NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
GlobeNewswire 11/12/2021 NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
GlobeNewswire 11/8/2021 NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November ...
GlobeNewswire 11/3/2021 NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
GlobeNewswire 10/20/2021 Bottomline Appoints Three New Directors to Board of Directors
GlobeNewswire 9/27/2021 NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference
GlobeNewswire 9/16/2021 SBM Offshore completes US$1.6 billion financing of Sepetiba
GlobeNewswire 9/10/2021 NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GlobeNewswire 8/18/2021 Aite-Novarica Group Announces Winners of the 2021 Digital Wallet Innovation Awards
GlobeNewswire 8/9/2021 NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
GlobeNewswire 8/9/2021 NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes